​
Login / Signup
Alvin A Morales-Giron
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 5
Top Topics
Crispr Cas
Small Cell Lung Cancer
Anti Inflammatory
Dna Binding
Top Venues
Cancer discovery
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Douglas A Rubinson
,
Noritaka Tanaka
,
Ferran Fece de la Cruz
,
Kevin S Kapner
,
Michael H Rosenthal
,
Bryanna L Norden
,
Haley Barnes
,
Sara Ehnstrom
,
Alvin A Morales-Giron
,
Lauren K Brais
,
Christopher T Lemke
,
Andrew J Aguirre
,
Ryan B Corcoran
Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers.
Cancer discovery
(2024)
Douglas A Rubinson
,
Noritaka Tanaka
,
Ferran Fece de la Cruz
,
Kevin S Kapner
,
Michael H Rosenthal
,
Bryanna L Norden
,
Haley Barnes
,
Sara Ehnstrom
,
Alvin A Morales-Giron
,
Lauren K Brais
,
Christopher T Lemke
,
Andrew J Aguirre
,
Ryan B Corcoran
Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers.
Cancer discovery
(2024)
Douglas A Rubinson
,
Noritaka Tanaka
,
Ferran Fece de la Cruz
,
Kevin S Kapner
,
Michael H Rosenthal
,
Bryanna L Norden
,
Haley Barnes
,
Sara Ehnstrom
,
Alvin A Morales-Giron
,
Lauren K Brais
,
Christopher T Lemke
,
Andrew J Aguirre
,
Ryan B Corcoran
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers.
Cancer discovery
14 (5) (2024)
Douglas A Rubinson
,
Noritaka Tanaka
,
Ferran Fece de la Cruz
,
Kevin S Kapner
,
Michael H Rosenthal
,
Bryanna L Norden
,
Haley Barnes
,
Sara Ehnstrom
,
Alvin A Morales-Giron
,
Lauren K Brais
,
Christopher T Lemke
,
Andrew J Aguirre
,
Ryan B Corcoran
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers.
Cancer discovery
14 (5) (2024)
Douglas A Rubinson
,
Noritaka Tanaka
,
Ferran Fece de la Cruz
,
Kevin S Kapner
,
Michael H Rosenthal
,
Bryanna L Norden
,
Haley Barnes
,
Sara Ehnstrom
,
Alvin A Morales-Giron
,
Lauren K Brais
,
Christopher T Lemke
,
Andrew J Aguirre
,
Ryan B Corcoran
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers.
Cancer discovery
14 (5) (2024)